Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins

Journal of Immunological Methods

Volumn 249, Issue 1-2, 2001, Pages 111-119

  Tham, Ee Loon ^a   Jensen, Paige L ^b   Mescher, Matthew F ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b RandD Systems Inc   (United States)

^c Mayo Mail Code 609   (United States)

Author keywords

Artificial cell surface constructs; Costimulation; Lymphocyte activation

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICROSPHERE; PHYTOHEMAGGLUTININ; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; CELLS, IMMOBILIZED; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOLOGIC TECHNIQUES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0035283051     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00335-5     Document Type: Article

References (20)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. T cell receptor and CD8-dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: Activation of p56lck by CD8 binding to class I protein
3. Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation
4. Cutting edge: A test of the dominant negative signal model for TCR antagonism
5. B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells
6. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
7. CD28/B7 costimulation: A review
8. T cell receptor antagonist peptides induce positive selection
9. CD28/B7 system of T cell costimulation
10. Surface contact requirements for activation of cytotoxic T lymphocytes
11. Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes
12. Immunotherapy of established murine tumors with large multivalent immunogen and cyclophosphamide
13. Stimulation of tumor-specific immunity using tumor cell plasma membrane antigen
14. The role of p21ras in CD28 signal transduction: Triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras
15. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28
16. Augmentation of in vivo cytotoxic T lymphocyte activity and reduction of tumor growth by large multivalent immunogen
17. A cell culture model for T lymphocyte clonal anergy
18. Characterization of recombinant soluble human transforming growth factor-β receptor type II (rhTGF-β sRII)
19. A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies
20. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity